BiophysicsbioRxivPreprint
Docking 14 million virtual isoquinuclidines against the mu and kappa opioid receptors reveals dual antagonists-inverse agonists with reduced withdrawal effects
Seth F. Vigneron, Shohei Ohno, Joao M. Braz…·Brian K. Shoichet
The paper screens 14.6 million virtual isoquinuclidines against opioid receptors to identify dual antagonists-inverse agonists with reduced withdrawal effects compared to naloxone.
3 citations